September 2014 FDA Recall Diclofenac Sodium And Misoprostol by Actavis Laboratories, Fl, Inc.
D-0258-2015 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Actavis Laboratories, Fl, Inc. on September 26, 2014 for the product Diclofenac Sodium And Misoprostol. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0258-2015

Reason for Recall
Failed Tablet/Capsule Specifications: Presence of split or broken tablets.
Initiated
09-26-2014
Reported
12-03-2014
Quantity
5,451 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Actavis Laboratories, FL, Inc.
U.S. Nationwide including Puerto Rico.
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only. Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC: 0591-0398-60, UPC 3 05910 39860 6.

Batch or Lot Expiration Information

Lot# 694320A, Expiry: 02/28/2015.